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Abstract: Dietary supplementation with spray-dried porcine plasma (SDP) can modulate the
immune response of gut-associated lymphoid tissue. SDP supplementation reduces acute mucosal
inflammation, as well as chronic inflammation associated with aging. The aim of this study was to
analyze if SDP supplementation could ameliorate colitis in a genetic mouse model of inflammatory
bowel disease (IBD). Wild-type mice and Mdr1a knockout (KO) mice were administered a control
diet or an SDP-supplemented diet from day 21 (weaning) until day 56. The histopathological index,
epithelial barrier, and intestinal immune system were analyzed in the colonic mucosa. KO mice
had higher epithelial permeability, increased Muc1 and Muc4 expression, and lower abundance
of E-cadherin and Muc2 (all p < 0.001). SDP prevented these effects (all p < 0.05) and decreased
the colonic inflammation observed in KO mice, reducing neutrophil and monocyte infiltration and
activation and the percentage of activated T helper lymphocytes in the colonic mucosa (all p < 0.05).
SDP also diminished proinflammatory cytokine expression and increased the anti-inflammatory IL-10
concentration in the colonic mucosa (all p < 0.05). In conclusion, dietary supplementation with SDP
enhances colon barrier function and reduces mucosal inflammation in a mouse model of IBD.
Keywords: spray-dried plasma; anti-inflammatory; colitis; barrier function
1. Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract
that is classically divided into Crohn disease and ulcerative colitis. In IBD, which is characterized
by alternative recurrence and alleviation periods, patients suffer from abdominal pain, diarrhea,
bloody stools, and weight loss [1]. It is a global disease, with increasing incidence and prevalence
around the world [2].
The etiopathogenesis of IBD has not yet been elucidated, but environmental, gut microbial,
and genetic factors all play important roles [3]. The intestinal inflammatory response in patients with
IBD also involves deregulation of gut-associated lymphoid tissue (GALT) [4]. This tissue is divided
into inductive sites, which include the mesenteric lymph nodes, Peyer’s patches (in the small intestine),
colonic patches, and isolated lymphoid follicles, and into effector sites, which include intraepithelial
lymphocytes and lymphocytes from the lamina propria [5]. Dysfunction of the innate and adaptive
immune responses triggers the release of numerous proinflammatory cytokines, such as tumor necrosis
factor-alpha (TNF-α) and interferon-gamma (IFN-γ), which results in epithelial cell damage and
Int. J. Mol. Sci. 2020, 21, 6760; doi:10.3390/ijms21186760 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2020, 21, 6760 2 of 16
apoptosis and alteration of the epithelial barrier [4]. The epithelial barrier comprises epithelial cells
(enterocytes), tight junction proteins, and the mucosal layer [6] and constantly interacts with the
underlying immune cells of the GALT [7]. In IBD patients, the integrity of the epithelial barrier is
compromised, as shown by increased paracellular permeability and lower levels of tight junction
proteins [8].
Although some drugs are able to modify the course of the disease and maintain remission,
they are not effective in all patients and their long-term use may have adverse effects [9]. Therefore,
alternative treatment strategies for IBD are necessary. Nutritional interventions may be a good
candidate. Using the Mdr1a knockout (KO) mouse model of colitis [10,11], we previously showed
that serum-derived bovine immunoglobulins (SBI) reduce colon permeability and the expression
of oxidative markers and proinflammatory cytokines in the colonic mucosa, as well as leukocyte
infiltration in the lamina propria and mesenteric lymph nodes [12,13]. Moreover, SBIs improve
mucositis symptoms, tissue damage scores, and neutrophil and lymphocyte percentages in a rat model
of mucositis [14].
Another dietary supplement that is widely used in farm animals to enhance growth and reduce both
morbidity and mortality is spray-dried porcine plasma (SDP) [15,16]. This supplement can modulate the
intestinal immune response to inflammatory agents. For example, it reduces T lymphocyte activation,
preventing the release of proinflammatory cytokines, and improves the mucosal barrier function after
staphylococcal enterotoxin B challenge in rodents [17–19]. In senescent mice, SDP supplementation
reduces nonspecific basal immune activation associated with age (inflammaging) by promoting mucosal
regulatory T helper (Th) lymphocytes (Treg lymphocytes) and interleukin (IL)-10 production [18].
Moreover, SDP attenuates cognitive decline and reduces brain capillary permeability, oxidative stress,
and proinflammatory cytokine expression in the brain of senescent mice [20].
Given the ability of SBI effects reducing the severity of colitis in the Mdr1a KO mouse model [12,13],
we wanted to study if SDP, a compound with well-documented antioxidant and anti-inflammatory
activities, can also modulate the immune response and ameliorate colitis in this animal model.
2. Results
2.1. Morphological Effects of SDP in Mdr1a KO Mice
Colon of Mdr1a knockout (KO) mice were shorter and thicker than those of wild-type (WT)
animals (p < 0.001; Figure 1A–C). The differences in colon diameter and wall thickness are clearly
evident in the colon sections shown in Figure 1D. The SDP supplementation reduced colon weight and
the ratio between colon weight and length (both, p < 0.001) while had no effects on colon length.
Histopathological and disease activity indices were increased in colitic mice (both p < 0.001;
Figure 1E,F, respectively) and SDP supplementation had no significant effects. With the exception of
ulceration, all specific parameters analyzed in the morphological study—mucus depletion, cryptitis,
and lamina propria and transmural inflammation—were augmented in KO mice (all p < 0.05), and SDP
did not modify these effects.
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Figure 1. Effects of spray-dried porcine plasma (SDP) supplementation on colon morphology in 
Mdr1a knockout (KO) mice. (A) Colon length. (B) Colon weight. (C) Ratio between colon weight and 
colon length. (D) Representative images of hematoxylin and eosin staining from a histopathological 
study of the colonic mucosa. Top images were taken at low magnification (×2), whereas bottom 
images were taken at high magnification (×20). (E) Histopathological index. (F) Disease activity index. 
In panels A to C, results are expressed as mean ± SEM (n = 6–9 mice/group). In panels D and E, results 
are expressed as median (n = 5–12 mice/group). Means without a common letter differ, p < 0.05. CTL, 
control; Int, indicates the interaction between colitis and diet. 
2.2. Effects of SDP on Colon Permeability in Mdr1a Knockout Mice 
We next analyzed crypt permeability using 4KDa fluorescein isothiocyanate (FITC)-dextran 
accumulation (Figure 2A). The KO mice showed increased crypt permeability in the colon (p = 0.001; 
Figure 2B), with SDP supplementation preventing this increase (p = 0.001). Moreover, KO mice 
exhibited lower levels of β-catenin (p = 0.003, Figure 2C,D) and E-cadherin (p = 0.001, Figure 2C,E). E-
cadherin abundance has been modified by SDP supplementation (p = 0.010), preventing the reduction 
observed in KO mice (p = 0.046). 
Figure 1. Effects of spray-dried porcine plasma (SDP) supplementation on colon morphology in Mdr1a
knockout (KO) mice. (A) Colon length. (B) Colon weight. (C) Ratio between colon weight and colon
length. (D) Representative images of hematoxylin and eosin staining from a histopathological study of
the colonic mucosa. Top images were taken at low magnification (×2), whereas bottom images were
taken at high magnification (×20). (E) Histopathological index. (F) Disease activity index. In panels
A to C, results are expressed as mean ± SEM (n = 6–9 mice/group). In panels D and E, results are
expre sed as median (n = 5–12 mic /group). Means without a common letter differ, p < 0.05. CTL,
control; Int, indicates the interaction between colitis and diet.
2.2. Effects of SDP on Colon Permeability in Mdr1a Knockout Mice
We next analyzed crypt permeability using 4KDa fluorescein isothiocyanate (FITC)-dextran
accumulation (Figure 2A). The KO mice showed increased crypt permeability in the colon (p = 0.001;
Figure 2B), with SDP supplementation preventing this increase (p = 0.001). Moreover, KO mice
exhibited lower levels of β-catenin (p = 0.003, Figure 2C,D) and E-cadherin (p = 0.001, Figure 2C,E).
E-cadherin abundance has be n modified by SDP supplementation (p = 0.010), preventing th reduction
o served in KO mice (p = 0.046).
KO mice showed increased expression of the transmembrane mucin 1 (Muc1) and mucin 4 (Muc4;
both p < 0.001, Table 1). SDP supplementation reduced Muc1 expression in KO mice (p = 0.016) and
diminished Muc4 expression in both WT and KO mice (p = 0.005). KO mice showed a substantial
decrease in the expression of the secretory mucin 2 (Muc2; p < 0.001) and SDP supplementation
attenuated this reduction (p = 0.023). Mucin 6 (Muc6) expression was similar in the two mouse groups
and was also not altered by SDP supplementation. The KO animals had a lower expression of trefoil
factor 3 (Tff3) than WT mice (p = 0.036) and SDP supplementation attenuated this effect, resulting in
similar expression to that seen in WT mice (Interaction p = 0.053). Goblet cell number was examined
using periodic acid-Schiff staining (Figure 3A). KO mice also had a lower number of goblet cells
(p < 0.001, Figure 3B).
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Figure 2. Effects of SDP supplementation on crypt permeability in the colonic mucosa of Mdr1a KO 
mice. (A) Representative images of FITC-dextran accumulation in the pericryptal sheath of the colonic 
mucosa after 15 min. All images were taken at the same magnification (×63). (B) Quantification of 
FITC-dextran accumulation in the pericryptal sheath of the colonic mucosa. (C) Representative 
Western blots of β-catenin (92 kDa), E-cadherin (132 kDa), and GAPDH (36 kDa). (D) β-catenin 
abundance in the colonic mucosa. (E) E-cadherin abundance in the colonic mucosa. Results are 
expressed as mean ± SEM (n = 5–7 mice/group). CTL, control; Int., indicates the interaction between 
colitis and diet; MW, molecular weight; SDP, spray-dried porcine plasma. 
KO mice showed increased expression of the transmembrane mucin 1 (Muc1) and mucin 4 
(Muc4; both p < 0.001, Table 1). SDP supplementation reduced Muc1 expression in KO mice (p = 0.016) 
and diminished Muc4 expression in both WT and KO mice (p = 0.005). KO mice showed a substantial 
decrease in the expression of the secretory mucin 2 (Muc2; p < 0.001) and SDP supplementation 
attenuated this reduction (p = 0.023). Mucin 6 (Muc6) expression was similar in the two mouse groups 
and was also not altered by SDP supplementation. The KO animals had a lower expression of trefoil 
factor 3 (Tff3) than WT mice (p = 0.036) and SDP supplementation attenuated this effect, resulting in 
similar expression to that seen in WT mice (Interaction p = 0.053). Goblet cell number was examined 
using periodic acid-Schiff staining (Figure 3A). KO mice also had a lower number of goblet cells (p < 
0.001, Figure 3B). 
Table 1. Effects of SDP Supplementation on The Expression of Mucin 1 (Muc1), Mucin 2 (Muc2), Mucin 
4 (Muc4), Mucin 6 (Muc6), and trefoil factor 3 (Tff3) in The Colonic Mucosa of Mdr1a knockout (KO) 
Mice. 
 WT KO p Value 
CTL SDP CTL SDP Colitis Diet Int. 
Muc1  1.00 ± 0.04 1.98 ± 0.03 5.90 ± 0.50 5.00 ± 0.36 <0.001 ns 0.016 
Muc2  1.00 ± 0.09 0.84 ± 0.04 0.21 ± 0.03 0.35 ± 0.03 <0.001 ns 0.023 
Muc4  1.00 ± 0.17 0.59 ± 0.02 2.86 ± 0.31 1.85 ± 0.10 <0.001 0.005 ns 
Muc6  1.00 ± 0.20 0.96 ± 0.36 1.17 ± 0.17 0.90 ± 0.15 ns ns ns 
Tff3  1.00 ± 0.16 0.97 ± 0.09 0.42 ± 0.08 0.92 ± 0.13 0.036 ns 0.053 
Results are expressed as mean ± SEM (n = 3–5 mice/group). CTL, control; Int., interaction between 
colitis and dietary factors; Muc1, mucin 1; Muc2, mucin 2; Muc4, mucin 4; Muc6, mucin 6; ns, 
nonsignificant; SDP, spray-dried porcine plasma; Tff3, trefoil factor 3. 
Figure 2. Effects of SDP supplementation on crypt permeability in the colonic mucosa of Mdr1a KO
mice. (A) Representative images of FITC-dextran accumulation in the pericryptal sheath of the colonic
mucosa after 15 min. All images were taken at the same magnification (×63). (B) Quantification of
FITC-dextran accumulation in the pericryptal sheath of the colonic mucosa. (C) Representative Western
blots of β-catenin (92 kDa), E-cadherin (132 kDa), and GAPDH (36 kDa). (D) β-catenin abundance
in the c lonic mucosa. (E) E-cadherin abundance in the colonic mucosa. Results are expressed as
mean ± SEM (n = 5–7 mice/group). CTL, control; Int., indicates the interaction between colitis and diet;
MW, molecular weight; SDP, spray-dried porcine plasma.
Table 1. Effects of SDP Supplementation on The Expression of Mucin 1 (Muc1), Mucin 2 (Muc2), Mucin 4
(Muc4), Mucin 6 (Muc6), and trefoil factor 3 (Tff3) in The Colonic Mucosa of Mdr1a knockout (KO) Mice.
WT KO p Value
CTL SDP CTL SDP Colitis Diet Int.
Muc1 1.00 ± 0.04 1.98 ± 0.03 5.90 ± 0.50 5.00 ± 0.36 < .001 ns 0.016
Muc2 1.00 ± 0.09 0.84 ± 0.04 0.21 ± 0.03 0.35 ± 0.03 <0.001 ns 0.023
Muc4 1.00 ± 0.17 0.59 ± 0.02 2.86 ± 0.31 1.85 ± 0.10 <0.001 0.005 ns
Muc6 1.00 ± 0.20 0.96 ± 0.36 1.17 ± 0.17 0.90 ± 0.15 ns ns ns
Tff3 1.00 ± 0.16 0.97 ± 0.09 0.42 ± 0.08 0.92 ± 0.13 0.036 ns 0.053
Results are expressed as mean ± SEM (n = 3–5 mice/group). CTL, control; Int., interaction between colitis and
dietary factors; Muc1, mucin 1; Muc2, mucin 2; Muc4, mucin 4; Muc6, mucin 6; ns, nonsignificant; SDP, spray-dried
porcine plasma; Tff3, trefoil factor 3.
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Figure 3. Effects of SDP supplementation on the levels of goblet cells in the colonic mucosa of Mdr1a 
KO mice. (A) Representative images periodic acid-Schiff staining of goblet cells in colon tissue. Images 
were taken at ×10 magnification. (B) Quantification of goblet cells in the colonic mucosa. Results are 
expressed as mean ± SEM (n = 5–7 mice/group). 
2.3. Effects of SDP on the Immune System in the Lamina Propria and Intraepithelial Lymphocytes in Mdr1a 
KO Mice 
KO mice showed considerable immune cell recruitment in the lamina propria (p < 0.001, Table 
2). The SDP supplementation reduced the immune cell infiltration (p = 0.003), but this reduction was 
higher in KO mice (p = 0.011). The levels of neutrophils and monocytes, as well as the percentages of 
activated neutrophils and monocytes, were higher in KO than WT mice (all p < 0.001) and SDP 
reduced these effects (p = 0.034; p = 0.044, p = 0.024, and p = 0.002, respectively). KO mice had a lower 
percentage of dendritic cells (p < 0.001) but the percentage of activated cells tended to be higher (p = 
0.063). On the other hand, dietary supplementation with SDP enhanced the abundance of this subset 
of cells, as well as their activation in the lamina propria, in both mouse groups (both p < 0.001). In KO 
mice, there was an increase in the percentage of activated Th lymphocytes (p < 0.001) and SDP 
supplementation reduced this percentage in both animal groups (p = 0.009). On the other hand, 
although the percentage of Treg lymphocytes was augmented in KO mice (p < 0.001), SDP increased 
this percentage more in KO mice than in WT mice (p = 0.022), resulting in a lower ratio between 
activated Th and Treg lymphocytes (p < 0.001). 
KO mice had more infiltrated immune cells in the intraepithelial compartment than WT mice, 
and the levels of monocytes and neutrophils were increased (all p < 0.001, Table 3). Dietary 
supplementation reduced the amount of infiltrated immune cells and the percentage of neutrophils 
(both p < 0.001). In addition, KO mice had higher percentages of activated monocytes and activated 
neutrophils, and both subsets were reduced by SDP supplementation (p = 0.007 and p = 0.030, 
respectively). Dendritic cells and their activation were reduced in KO mice (p = 0.025 and p = 0.003, 
respectively), and SDP supplementation did not modify their percentage. Regarding activated Th 
and Treg lymphocytes, the former were increased in KO mice (p < 0.001) and were unchanged by SDP 
supplementation. In contrast, the abundance of the latter was not different between WT and KO mice 
but was increased by SDP supplementation (p < 0.001). Consequently, KO animals showed a higher 
ratio of activated Th to Treg lymphocytes than animals supplemented with SDP (both p < 0.001). 
  
Figure 3. Effects of SDP supplementation on the levels of goblet cells in the colonic mucosa of Mdr1a
KO mice. (A) Representative images periodic acid-Schiff staining of goblet cells in colon tissue. Images
were taken at ×10 magnification. (B) Quantification of goblet cells in the colonic mucosa. Results are
expressed as mean ± SEM (n = 5–7 mice/group).
2.3. Effects of SDP on the Immune System in the Lamina Propria and Intraepithelial Lymphocytes in Mdr1a
KO Mice
KO mice showed considerable immune cell recruitment in the lamina propria (p < 0.001, Table 2).
The SDP supplementation reduced the immune cell infiltration (p = 0.003), but this reduction was
higher in KO mice (p = 0.011). The levels of neutrophils and monocytes, as well as the percentages
of activated neutrophils and monocytes, were higher in KO than WT mice (all p < 0.001) and SDP
reduced these effects (p = 0.034; p = 0.044, p = 0.024, and p = 0.002, respectively). KO mice had a
lower percentage of dendritic cells (p < 0.001) but the percentage of activated cells tended to be higher
(p = 0.063). On the other hand, dietary supplement tion with SDP nhanced the abundance of this
subset of cells, as well as their activation in the lamina propria, in both mouse groups (bo h p < 0.001).
In KO mice, there was an inc ease in the percentage of activated Th lymphocytes (p < 0.001) and
SDP supplementation reduced this percentage in both animal groups (p = 0.009). On the other hand,
although the percentage of Treg lymphocytes was augmented in KO mice (p < 0.001), SDP increased
this percentage more in KO mice than in WT mice (p = 0.022), resulting in a lower ratio between
activated Th and Treg lymphocytes (p < 0.001).
Table 2. Effects of SDP Supplementation on The Immune Populations of The Lamina Propria of The
Colonic Mucosa of Mdr1a KO Mice.
WT KO p Value
CTL SDP CTL SDP Colitis Diet Int.
Cell count (×106) 1.55 ± 0.17 1.14 ± 0.19 16.0 ± 1.07 11.1 ± 0.97 <0.001 0.003 0.011
Monocytes 8.10 ± 0.58 7.74 ± 0.79 13.0 ± 0.49 10.5 ± 0.83 <0.001 0.044 ns
Act. monocy es 29.8 ± 2.72 27.1 ± 1.74 60.3 ± 1.70 49.3 ± 1.89 <0.001 0.002 ns
Neutrophils 19.0 ± 2.19 17.5 ± 2.52 38.9 ± 1.39 31.4 ± 2.08 <0.001 0.034 ns
Act. neutrophils 31.1 ± 2.78 25.7 ± 2.30 57.8 ± 2.21 51.5 ± 2.53 <0.001 0.024 ns
Dendritic cells 19.7 ± 1.50 23.7 ± 1.38 9.49 ± 0.41 12.2 ± 0.60 <0.001 <0.001 ns
Act. dendritic cells 4.51 ± 0.79 9.29 ± 1.29 6.36 ± 0.46 10.7 ± 1.34 0.063 <0.001 ns
Act. Th lymphocytes 6.80 ± 0.69 5.32 ± 0.58 17.0 ± 0.85 13.8 ± 0.60 <0.001 0.009 ns
Treg lymphocytes 3.26 ± 0.45 3.34 ± 0.53 5.77 ± 0.52 8.81 ± 0.55 <0.001 0.017 0.022
Act. Th/Tr g lym. ratio 2.51 ± 0.22 1.66 ± 0.19 3. 9 ± 0.27 1.60 ± 0.09 ns <0.001 0.040
Results are expressed as mean ± SEM (n = 5–14 mice/group). Cell valu s are expressed as absolute number for
cell count while monocytes, neutrophils, and dendritic cells are expressed as the percentage of nonlymphocytic
leukocytes. Activated and regulatory cells are expressed as the percentage of the corresponding total subset. Act.,
activated; CTL, control; Int., interaction between colitis and dietary factors; ns, nonsignificant; SDP, spray-dried
porcine plasma; Th, T helper; Treg; regulatory T helper.
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KO mice had more infiltrated immune cells in the intraepithelial compartment than WT mice,
and the levels of monocytes and neutrophils were increased (all p < 0.001, Table 3). Dietary
supplementation reduced the amount of infiltrated immune cells and the percentage of neutrophils
(both p < 0.001). In addition, KO mice had higher percentages of activated monocytes and activated
neutrophils, and both subsets were reduced by SDP supplementation (p = 0.007 and p = 0.030,
respectively). Dendritic cells and their activation were reduced in KO mice (p = 0.025 and p = 0.003,
respectively), and SDP supplementation did not modify their percentage. Regarding activated Th and
Treg lymphocytes, the former were increased in KO mice (p < 0.001) and were unchanged by SDP
supplementation. In contrast, the abundance of the latter was not different between WT and KO mice
but was increased by SDP supplementation (p < 0.001). Consequently, KO animals showed a higher
ratio of activated Th to Treg lymphocytes than animals supplemented with SDP (both p < 0.001).
Table 3. Effects of SDP Supplementation on The Immune Population of The Intraepithelial Compartment
In The Colonic Mucosa of Mdr1a KO mice.
WT KO p Value
CTL SDP CTL SDP Colitis Diet Int.
Cell count (×106) 0.26 ± 0.06 0.19 ± 0.05 1.76 ± 0.22 0.81 ± 0.10 <0.001 <0.001 0.003
Monocytes 9.39 ± 0.60 8.21 ± 1.55 12.8 ± 0.78 11.1 ± 0.91 <0.001 ns ns
Act. monocytes 5.90 ± 1.17 3.88 ± 0.49 19.6 ± 1.71 13.1 ± 0.58 <0.001 0.007 ns
Neutrophils 8.09 ± 0.75 5.61 ± 0.54 15.5 ± 0.94 9.82 ± 0.54 <0.001 <0.001 ns
Act. neutrophils 4.43 ± 1.13 6.31 ± 0.99 21.7 ± 1.83 12.7 ± 0.83 <0.001 0.030 0.002
Dendritic cells 20.1 ± 2.55 19.1 ± 2.22 15.0 ± 1.42 16.4 ± 0.76 0.025 ns ns
Act. dendritic cells 20.9 ± 2.78 20.0 ± 2.02 13.8 ± 0.68 17.7 ± 0.63 0.003 ns ns
Act. Th lymphocytes 6.08 ± 0.18 6.37 ± 0.76 16.1 ± 0.94 13.0 ± 0.74 <0.001 ns ns
Treg lymphocytes 3.10 ± 0.43 5.33 ± 0.26 3.39 ± 0.21 5.27 ± 0.47 ns <0.001 ns
Act. Th/Treg lym. ratio 2.09 ± 0.31 1.19 ± 0.09 4.83 ± 0.26 2.58 ± 0.18 <0.001 <0.001 0.015
Results are expressed as mean ± SEM (n = 5–14 mice/group). Cell values are expressed as absolute number for
cell count while monocytes, neutrophils, and dendritic cells are expressed as the percentage of nonlymphocytic
leukocytes. Activated and regulatory cells are expressed as the percentage of the corresponding total subset. Act,
activated; CTL, control; Int., interaction between colitis and dietary factors; ns, nonsignificant; SDP, spray-dried
porcine plasma; Th, T helper; Treg; regulatory T helper.
2.4. Effects of SDP Suplementation on Inflammation Markers in Mdr1a KO Mice
The concentrations of the chemokines MIP-1β and MCP-1 were augmented in the colonic mucosa
in KO mice (both p < 0.001, Figure 4A,B) and SDP supplementation reduced their levels (p = 0.026 and
p = 0.025, respectively). The concentrations of the cytokines IL-17 and Il-2 were also increased in KO
mice (p < 0.001, Figure 4C,D), with SDP supplementation once again blocking the increase (p = 0.026
and p = 0.012, respectively).I t. J. Mol. Sci. 020, 21, x FOR PEER REVIEW 7 of 16 
 
 
Figure 4. Effects of SDP supplementation on cytokine secretion in the colonic mucosa of Mdr1a KO 
mice. (A) MIP-1β concentration; (B) MCP-1 concentration; (C) IL-17 concentration; (D) IL-2 
concentration. Results are expressed as mean ± SEM (n = 5–7 mice/group). CTL, control; IL-2, 
interleukin-2; IL-17, interleukin-17; Int., interaction between colitis and dietary factors; MCP-1, 
monocyte chemoattractant protein 1; MIP-1β, macrophage inflammatory protein 1 beta; SDP, spray-
dried porcine plasma. 
In KO mice, the expression levels of Inos, Ifn-γ, and Tnf-α were increased (all p < 0.001, Figure 5), 
and SDP supplementation reduced all these effects (p = 0.041, p < 0.001, and p < 0.001, respectively). 
 
Figure 5. Effects of SDP supplementation on proinflammatory cytokine expression in the colonic 
mucosa of Mdr1a KO mice. (A) Inos expression; (B) Ifn-γ expression; (C) Tnf-α expression. Results are 
expressed as mean ± SEM (n = 4–7 mice/group). CTL, control; Inos, inducible nitric oxide synthase; 
Ifn-γ, interferon-gamma; Int., indicates the interaction between colitis and dietary factors; SDP, spray-
dried porcine plasma; Tnf-α, tumor necrosis factor-alpha. 
SDP supplementation increased the concentration of the anti-inflammatory cytokine IL-10 (p = 
0.049, Figure 6A). No changes in the TGF-β concentration were observed in the colonic mucosa in KO 
mice or after SDP supplementation (Figure 6B). 
 
Figure 6. Effects of SDP supplementation on anti-inflammatory cytokine secretion in the colonic 
mucosa of Mdr1a KO mice. (A) IL-10 concentration; (B) TGF-β concentration. Results are expressed as 
Figure 4. Effects of SDP supplementation on cytokine secretion in the colonic mucosa of Mdr1a KO mice.
(A) MIP-1β concentration; (B) MCP-1 concentration; (C) IL-17 concentration; (D) IL-2 concentration.
Results are expressed as mean ± SEM (n = 5–7 mice/group). CTL, control; IL-2, interleukin-2; IL-17,
interleukin-17; Int., interaction between colitis and dietary factors; MCP-1, monocyte chemoattractant
protein 1; MIP-1β, macrophage inflammatory protein 1 beta; SDP, spray-dried porcine plasma.
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In KO mice, the expression levels of Inos, Ifn-γ, and Tnf-α were increased (all p < 0.001, Figure 5),
and SDP supplementation reduced all these effects (p = 0.041, p < 0.001, and p < 0.001, respectively).
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SDP supple entation increased the concentration of the anti-inflammatory cytokine IL-10
(p = 0.049, Figure 6A). No changes in the TGF-β concentration were observed in the colonic mucosa in
KO mice or after SDP supplementation (Figure 6B).
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mucosa of Mdr1a KO mice. (A) IL-10 concentration; (B) TGF-β concentration. Results are expressed as
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3. Discussion
The pathogenesis of IBD is still unknown. However, it is well-established that patients have a
deregulated immune response involving increases in proinflammatory cytokines, which has been
identified to contribute to disorders of the gastrointestinal tract [21]. In recent years, nutraceutical
compounds, which include bioactive peptides and colostrum, have been reported to have beneficial
effects in IBD patients [22]. Therefore, in the present study, we evaluated the effects of dietary
supplementation with SDP on the evolution of IBD in a mouse model of spontaneous colitis.
The gastrointestinal tract can develop different inflammatory pathologies, with changes in
epithelial permeability leading to altered mucosal functions [23]. Here, Mdr1a KO mice showed
an increase in the histopathological index, indicating intestinal deterioration. In addition, KO mice
had higher epithelial permeability and lower abundance of tight junction proteins than WT animals,
which is consistent with the alterations in epithelial permeability and in tight junction structure
observed in patients with ulcerative colitis and Crohn disease [8]. Although SDP supplementation did
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not improve the histopathological index, it prevented the increase in crypt epithelial permeability and
the reduction in E-cadherin abundance observed in Mdr1a KO animals. This effect is similar to that
observed in the same model of colitis after supplementation with SBI, which is an immunoglobulin
concentrate [12]. Previous work has also shown that SDP can prevent increases in small intestine
permeability during acute intestinal inflammation induced by an enterotoxin [17].
IBD patients show lower abundance of goblet cells and changes in mucin expression and
secretion [24], which reduce the thickness of the mucus layer [25] and thereby compromise barrier
function. In addition to mucins, goblet cells also synthesize trefoil factors, which are secretory proteins
that stabilize the mucus layer [26] and facilitate intestinal epithelial restitution [27]. Our Mdr1a KO
mice showed a reduction in the number of goblet cells in the colon, as well as in the expression of
Muc2 and Tff3, which would contribute to an increase in the epithelial permeability of the colon [28].
Indeed, it has been described that a reduction in goblet cells and Muc2 would be associated with an
increase in pathogenic bacteria in the mucus layer and a greater penetration of these microorganisms
into the mucosa [29]. SDP supplementation did not improve goblet cell abundance in KO mice but
did attenuate the decrease in Muc2 expression and maintained Tff3 expression at similar levels to
those of healthy animals. Therefore, SDP helps to maintain barrier integrity and prevent the entry of
pathogenic microorganisms that could eventually perpetuate inflammation in the colonic mucosa.
Both MUC1 and MUC4 are membrane-bound mucins that are elevated in patients with IBD
during the inactive phase of the disease, suggesting a crucial role of these mucins in the development
of the condition [30]. In addition, aberrant expression of Muc1 is involved in intestinal barrier
dysfunction during inflammation, with overexpression of Muc1 correlated with increased intestinal
permeability [31]. On the other hand, neutrophil infiltration is associated with increased Muc4
expression [32]. SDP supplementation reduced the overexpression of Muc1 and Muc4 observed in
KO mice, suggesting that SDP-supplemented mice had lower immune activity and an enhanced
colon barrier.
Mdr1a KO mice showed an increase in immune cell recruitment in the lamina propria and in the
intraepithelial compartment, as observed in IBD patients [33]. This infiltration is triggered by monocytes,
neutrophils, and Th lymphocytes [34]. The infiltration is accompanied by chemokines and cytokines
that promote the recruitment and activation of these cells, leading to unrestrained accumulation of
activated immune cells that impair mucosal homeostasis and perpetuate the inflammatory response [35].
We found that SDP supplementation reduced the accumulation of activated monocytes and neutrophils
in the colonic mucosa, which is consistent with reduced production of MIP-1β and MCP-1. This effect
is notable because these chemokines are important mediators for the recruitment and accumulation
of neutrophils and macrophages in colitis models [36]. The SDP diet also reduced the percentage
of activated Th cells in the lamina propria, diminishing an immune subset that plays a main role in
initiating and shaping IBD pathogenesis [37]. The decline in Th cell activation led to a reduction
in proinflammatory cytokines, such as IL-2 and IFN-γ. This is noteworthy because activated Th
lymphocytes are also characterized by alterations in cytokine production, which result in a disturbed
balance between pro- and anti-inflammatory cytokines [38,39]. Along this line, similar effects of
SDP supplementation have been observed in other rodent models of jejunum and pulmonary acute
inflammation [40–42].
Th17 cells play an important role in host defense against extracellular pathogens but are also
associated with the development of inflammatory responses such as those seen in IBD [43]. Here,
Mdr1a KO mice showed a considerable increase in IL-17 release in the colonic mucosa, indicating a
clear bias toward the Th17 immune response. SDP decreased the concentration of IL-17 in the colonic
mucosa. This effect may be clinically relevant because IL-17 induces the release of chemokines and
other chemoattractants from epithelial and endothelial cells that promote the inflammatory response
through the recruitment of neutrophils [44]. Therefore, the reduced IL-17 release observed in KO
mice supplemented with SDP might explain the lower activation of neutrophils and their reduced
infiltration into the colonic mucosa. Similar effects of SDP supplementation were observed in mice
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with acute lung inflammation induced by lipopolysaccharide (LPS), with a reduction in the activation
of neutrophils and their infiltration into lung tissue [42,45].
Immune activation and proinflammatory cytokine release can disassemble tight junction proteins,
increasing epithelial permeability [46]. This can trigger and perpetuate local inflammation in IBD [47].
Furthermore, both Tnf-α and Ifn-γ induce Inos expression, which also has deleterious effects on intestinal
integrity [48]. In general, our results showed that SDP supplementation reduced the immune response
during colitis development. A similar pattern was also observed with SBI supplementation in Mdr1a
KO mice [13].
The intestinal mucosa is normally maintained in a state of controlled inflammation in which
there is a balance between protective immune responses and tolerance to self-antigen and commensal
bacteria [49]. Dendritic cells participate in the preservation of Th intestinal tolerance through the
activation and maintenance of Treg cells [50], which in turn control immune responses in the gut by
inhibiting the proliferation and effector functions of other T cells. Inflammation in IBD may be caused
by an alteration in the balance between Treg and proinflammatory activated Th cells [51]. Our KO
mice showed a reduced proportion of dendritic cells and activated dendritic cells, which correlates
well with the reduction in the Treg population. In our experiments, SDP supplementation increased
the percentage of dendritic cells and their activation in the lamina propria of the KO mice, as well
as the proportion of Treg lymphocytes in the colonic mucosa. SDP supplementation also reduced
the ratio between activated Th lymphocytes and Treg lymphocytes, indicating that SDP restores
the balance between these lymphocyte populations. A similar response pattern has been observed
in the Staphylococcal enterotoxin B model of mild intestinal inflammation [19] and in acute lung
inflammation induced by LPS [45]. In both cases, the challenge increased the activated Th/Treg ratio
while SDP restored the pre-challenge ratio. The importance of these effects lies in the role of Treg in the
suppression of Th effector cells through the secretion of anti-inflammatory cytokines such as IL-10 and
TGF-β [52].
SDP supplementation did not modify colon TGF-β concentration but did promote IL-10 release.
The lack of a TGF-β response was unexpected because, in other inflammation models, such as intestinal
and genitourinary acute inflammation models, SDP induces the secretion of TGF-β [41,53]. However,
in acute lung inflammation, only mature TGF-β (and not total TGF-β) is increased by SDP [42].
On the other hand, SDP supplementation increased the release of IL-10 during chronic
inflammation. These results are consistent with the acute intestinal inflammation induced by
staphylococcal enterotoxin B [19], with the acute lung inflammation provoked by LPS [42], and with the
uterine inflammation induced by stress [53], in which SDP supplementation increases the expression of
this anti-inflammatory cytokine. In a very different condition, such as in a mouse model of senescence,
SDP increases the brain concentration of IL-10, suggesting its participation in the regulation of immune
responses in nonmucosal tissues [20]. All of these effects of SDP on IL-10 are remarkable because this
cytokine plays an important anti-inflammatory role in restricting and suppressing the inflammatory
responses, thus minimizing tissue damage in response to microbial challenges [54].
Besides the effect of SDP on the immune system itself, it can also act through changes in the
intestinal microbiota. In this regard, Moretó et al. [55] showed that supplementation with SDP increases
the proportion of bacterial families that improve intestinal barrier function and are well-known
mediators of anti-inflammatory and tolerogenic responses, such as the Lactobacillaceae family. In fact,
different species of the genus Lactobacillus have been shown to be effective in promoting the expression
of Il-10 [22] or in reducing the expression of adhesion molecules that promote leukocyte recruitment in
an experimental colitis model [56].
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4. Materials and Methods
4.1. Animals and Experimental Design
Mdr1a knockout mice (FVB.129P2-Abcb1atm 1BorN7; KO mice) and the corresponding FVB wild
type (WT mice) were purchased from Taconics (Germtown, NY, USA). We created a stable colony for KO
animals in the specific pathogen free (SPF) area of the Animal Experimentation Service of the Barcelona
Science Park (BSP). Animals were kept under stable temperature and humidity conditions, with a
12 h:12 h light/dark cycle. All protocols used in this study were approved by the Ethics Committee for
Animal Experimentation of the BSP (Permit number: P03-R1-08, approved 09/05/2008).
The animals were weaned at day 21 of age and then consumed the experimental diets until the
end of the study. The animals were fed a control diet, or a diet supplemented with 8% of SDP, which is
a protein-rich ingredient obtained from industrial fractionation of blood from healthy pigs intended for
human consumption. Control and SDP diets were designed to provide balanced energy and nutrients.
The experimental diets were prepared by APC-Europe S.L.U (Granollers, Spain) from base ingredients
provided by Envigo (Bresso, Italy), and their composition is detailed in Table 4. The experimental
groups used throughout the study were WT (WT mice fed control diet), KO (KO mice fed control diet),
SDP (WT mice fed SDP diet), and KO-SDP (KO mice fed the SDP diet). Mice were maintained in the
SPF area until day 28 of age, when they were transferred to a conventional housing area. Animals were
killed by anesthesia overdose at 56 days of age.
Table 4. Diet composition.
Ingredients Control Diet Ingredients
SDP 1 - 80
Dried skim milk 530.7 340.5
Corn starch 199.3 308.8
Sucrose 94.5 94.5
Soybean oil 70 70
Cellulose 50 50
AIN-93-G-MX 2 35 35
AIN-93 VX 2 15 15
Choline bitartrate 3 3
Methionine 2.5 3.2
1 SDP (spray-dried porcine plasma) was provided by APC-Europe S.L.U (Granollers, Spain); 2 AIN-93 VX,
vitamin mix; AIN-93-G-MX, mineral mix, both provided by Envigo (Bresso, Italy).
The clinical signs of colitis were analyzed using the disease activity index (DAI), which scores
weight loss, stool consistency and bleeding, as described elsewhere [12].
4.2. Morphological Study
This procedure was carried out as described before [13]. Histopathological analysis was
performed by the Pathological Anatomy Department of the Vall d’Hebron Hospital (Barcelona, Spain),
under blind conditions. Analysis of the degree of histological alterations assigned values between 0–3
(absent-slight-moderate-severe). The variables studied were lamina propria and transmural cellular
infiltration, cryptitis, ulcers and mucus depletion.
4.3. Intraepithelial Lymphocytes and Lamina Propria Lymphocytes Isolation
Lymphocytes isolation was carried out as previously described [13,57]. Briefly, the colon was
extracted, washed with PBS and everted. Then, the tissue was incubated in a pre-digestion solution HBSS
with 10% FBS (both Invitrogen, Carlsbad, CA, USA), 5 mM EDTA and 1 mM DTT (both Sigma-Aldrich,
St. Louis, MO, USA) for 25 min at 37 ◦C in a shaker (Thermomixer Comfort Eppendorf®, 750 rpm).
The cell suspension was filtered in a cell strainer of 75 µm and centrifuged at 500× g for 10 min at 4 ◦C.
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The pelleted cells were resuspended in PBS-FBS and reserved until do the Percoll gradient. The cell
suspension contains intraepithelial lymphocytes among other cell types.
The remainder colon was finely minced and incubated in digestion solution containing RPMI 1640,
5% FBS, penicillin/streptomycin, 10 nM HEPES, 2 mM L-Glutamine and 1500 U/mL collagenase (all,
Invitrogen, Carlsbad, CA, USA) at 37 ◦C for 20 min in a shaker (Thermomixer Comfort Eppendorf®,
750 rpm). The cell suspension obtained was separated and the rest of tissue was incubated two
additional times with the digestion solution. The cell suspension obtained was filtered in a 75 µm cell
strainer and centrifuged at 500× g for 10 min at 4 ◦C. The pelleted cells were resuspended in PBS-FBS.
This cell suspension contains the lamina propria lymphocytes among others cell types.
At this point, both types of enriched cell suspensions (from lamina propria and intraepithelial
compartment) were proceed at the same time. Samples were centrifuged at 500× g for 10 min at
4 ◦C and were submit to gradient Percoll 40–80%. Leukocytes were transferred to a clean tube and
centrifuged at 500× g for 10 min at 4 ◦C. The pelleted cells were resuspended in PBS-FBS. Cell number
and viability were determined using acridine orange and ethidium bromide markers. In all cases,
cell viability was >90%.
4.4. Cell Staining
Cell staining was performed as described before [13]. Briefly, the staining was carried out on 1.5 ×
104 cells in samples of the lamina propria, and on 7 × 104 cells of the intraepithelial subset. To stain
extracellular markers, cells were incubated with the primary antibodies CD45, CD19, CD4, CD25, CD14
and CD11c (all from eBioscience Inc., San Diego, CA, USA) and LY6G and CD86 (BD Pharmingen,
Franklin Lakes, NJ, USA) for 30 min at 4 ◦C. To stain the intracellular markers, cells were fixed with
paraformaldehyde 4% for 20 min at 4 ◦C (Sigma-Aldrich, St. Louis, MO, USA), and permeabilized
with Triton-X® for 15 min at 4 ◦C (Sigma-Aldrich, St. Louis, MO, USA). Cells were incubated with
the primary antibodies FOXP3 (eBioscience Inc. San Diego, CA, USA) and CD68 (Serotec GmbH
Kidlington, UK) for 30 min at 4 ◦C. Finally, cells were maintained in paraformaldehyde 4% until
further analysis in the Aria cell sorter (Becton Dickinson, Franklin Lakes, NJ, USA) located at the
Cytometry Unit of the Technical Services of the Universitat de Barcelona at the BSP. Results were
analyzed using the Flowjo Software (Treestar Inc., Ashland, OR, USA). Cell markers to quantify each
leukocyte population are detailed in Table 5.




T helper cells CD4+CD45+
Activated Th lymphocytes CD25+FOXP3−CD4+
Regulatory Th lymphocytes CD25+FOXP3+CD4+
Neutrophils CD45+ non-lymphocytic leucocytes were separated by forward/side scatter Ly6G+
Monocytes CD45+ non-lymphocytic leucocytes were separated by forward/side scatter CD68+
Activated neutrophils CD45+ non-lymphocytic leucocytes were separated by forward/side scatter Ly6G+CD14+
Activated monocytes CD45+ non-lymphocytic leucocytes were separated by forward/side scatter CD68+CD14+
Dendritic cells CD11c+CD45+
Activated dendritic cells CD45+CD11c+CD86+
4.5. Epithelial Fluorescent Dextran Permeability
This protocol was performed as previously described [12]. Briefly, the colon mucosa was scrapped
and kept for 15 min in a petri dish which contained carbogenated Earl’s solution at 37 ◦C to stabilize
the sample. The fluorescent tracer fluorescein isothiocyanate (FITC)-labeled dextran (FITC-dextran;
molecular weight 4000; Sigma-Aldrich, St. Louis, MO, USA) was used to study the crypt permeability.
To carry out the monitoring of the ratio of fluorescence intensity of crypt luminal and pericryptal areas,
tissue samples were incubated for 15 min and confocal images were taken every 3 min with a CLSM
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SPII confocal microscope (Leica Microsystems, Heidelberg, Germany). Two fields were captured per
tissue per animal. The image was quantified with ImageJ software.
4.6. Western Blot
This procedure was carried out as described before [55]. Samples of colon mucosa were
homogenized. Equal amounts of protein (100 µg) were separated on 10% SDS-PAGE and transferred
to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). Membranes were incubated
overnight at 4 ◦C with specific primary antibodies against GAPDH (clone GAPDH-71.1; 1:10,000;
Sigma-Aldrich, St. Louis, MO, USA), β-catenin (1:2000; NeoMarkers, Fremont, CA, USA), E-cadherin
(clone H-108, 1:500; Santa Cruz Biotechnology, Dallas, TX, USA). The blots were developed by using
WesternDot 625 Western blot kits (Life Technologies, Paisley, UK) and quantified with ImageJ gel
analyser software.
4.7. Real-Time PCR
RNA isolation, reverse transcription was performed as describe previously [20]. Total RNA was
retrotranscribed using an iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA). Real-time PCR
was performed using a cDNA template in a 20 µL reaction containing 0.2 µmol/L of each primer
and SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) and carried out
on a MiniOpticon Real-Time PCR System (Bio-Rad, Hercules, CA, USA). The primers used to detect
the genes of interest were cited elsewhere [18,45]. The target gene transcripts were quantified using
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expression as a reference, using the 2−∆∆Ct
method [58]. Product fidelity was confirmed by melt-curve analysis.
4.8. Cytokine Concentration
Samples of colon mucosa were homogenized as described before [13]. Cytokines were measured
by Bio-Plex Cytokine Assay™ (Bio-Rad, Hercules, CA, USA).
4.9. Statistical Analysis
Results are presented as means ± SEM except for the disease activity index score, histopathological
index and parameters used in the histopathological index, which are expressed as medians. A test was
performed to detect outliers (Grubb test) and check the homogeneity of variance (Shapiro-Wilk test)
and data normality (Shapiro–Wilk test) for all groups. Median values for nonparametric data were
compared by the Kruskal-Wallis test. The effects of diet, colitis as well as their interaction (diet and
colitis factors) were analyzed by two-way ANOVA followed by Fisher’s Least Significant Difference
(LSD) post hoc test (applied between the different diets), using GraphPad Prism® software v 7.01
(GraphPad Software, Inc., La Jolla, CA, USA). Statistical differences were considered significant at
p < 0.05. A p value between 0.05 and 0.1 was suggestive of a true effect [59].
5. Conclusions
In conclusion, our findings showed that dietary supplementation with SDP reduces the amount of
activated Th lymphocytes and promotes the presence of Treg cells in mice that spontaneously develop
colitis; in turn, SDP increases the secretion of Il-10, which favored an anti-inflammatory immune
profile. This cascade eventually reduces proinflammatory cytokines in the mucosa and restores the
barrier properties of the colonic epithelium. The beneficial effect of SDP in this model suggests a role
for plasma-derived supplements in preventing and ameliorating IBD.
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GALT Gut-associated lymphoid tissue
IBD Inflammatory bowel disease
IFN-γ Interferon-gamma
IL Interleukin
Inos Inducible nitric oxide synthase
KO Knockout
MCP-1 Monocyte chemoattractant protein 1






SDP Spray-dried porcine plasma
Tff3 Trefoil factor 3
TGF-β Transforming growth factor-beta
Th T helper
Treg Regulatory Th lymphocytes
TNF-α Tumor necrosis factor-alpha
WT Wild type
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